Lyka Labs P/B Ratio
LYKALABS • Price-to-Book ratio analysis and book value breakdown
Current P/B Ratio
2.13
Moderate Valuation
High - Premium to book value, growth expectations or asset-light model
Current Valuation Metrics
P/B Ratio
2.13
Current Price
₹56.50
Book Value/Share
₹28.89
Exchange
NSE
Book Value Breakdown (2025)
Balance Sheet Components
Total Equity
₹104 Cr
Share Capital
₹36 Cr
Reserves & Surplus
₹68 Cr
Outstanding Shares
36,000,000
Book Value per Share
₹28.89
Valuation Signal
Signal
Fairly Valued
Historical Avg
11.38
Historical Range
2.63 - 26.87
Percentile
0.0%
Sector Context
Sector Average
-0.15
Sector Median
0.63
Sector Rank
#11 of 50
Sector Percentile
22.0%
Key P/B Ratio Insights for Lyka Labs
- Current PB is 81.3% below historical average
- Trading at premium to sector average PB of -0.15
View the current stock price of Lyka Labs for more insights.
P/B Ratio Historical Trend for Lyka Labs
Historical P/B ratio trend based on balance sheet data. P/B below 1.0 may indicate undervaluation, while higher ratios suggest growth expectations or asset-light business models.
Related Pages for Lyka Labs
Additional stock information and data for LYKALABS
Historical P/B Ratio Data
| Year | P/B Ratio | Book Value/Share (₹) | Year-end Price (₹) | Total Equity (₹ Cr) | Valuation |
|---|---|---|---|---|---|
| 2025 | 2.63 | ₹28.89 | ₹75.89 | ₹104 | Moderate |
| 2024 | 7.66 | ₹20.61 | ₹157.82 | ₹68 | High |
| 2023 | 8.34 | ₹14.84 | ₹123.75 | ₹46 | High |
| 2022 | 26.87 | ₹4.83 | ₹129.70 | ₹14 | High |
Sector P/B Ratio Comparison
Comparing Lyka Labs with other companies in Healthcare sector
Sector Average
-0.15
Sector Median
0.63
Lowest P/B
-11.38
Highest P/B
1.09
Companies
50
| Company | Symbol | P/B Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Sun Pharma Advanced Rese… | SPARC | -11.38 | ₹4,036 | Low |
| Span Divergent | SDL | -6.32 | ₹19 | Low |
| Oxygenta Pharmaceutical | OXYGENTAPH | -5.54 | ₹203 | Low |
| Satiate Agri | SATAGRI | -3.39 | ₹8 | Low |
| Adline Chem Lab | ADLINE | -3.03 | ₹5 | Low |
| Bharat Immunologicals | BIBCL | -2.47 | ₹95 | Low |
| Parmax Pharma | PARMAX | -2.15 | ₹12 | Low |
| Krebs Biochemicals & Ind… | KREBSBIO | -0.96 | ₹154 | Low |
| Cresanto Global | CRESANTO | -0.67 | ₹2 | Low |
| Triochem Products | TRIPR | 0.04 | ₹0 | Low |